Olink publishes 2023 annual report
25 Março 2024 - 9:00AM
Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced
that the Annual Report for 2023 is now available on the Company’s
website at https://investors.olink.com/.
About OlinkOlink Holding AB
(Nasdaq: OLK) is a company dedicated to accelerating proteomics
together with the scientific community, across multiple disease
areas to enable new discoveries and improve the lives of patients.
Olink provides a platform of products and services which are
deployed across major biopharmaceutical companies and leading
clinical and academic institutions to deepen the understanding of
real-time human biology and drive 21st century healthcare through
actionable and impactful science. The Company was founded in 2016
and is well established across Europe, North America, and Asia.
Olink is headquartered in Uppsala, Sweden.
IR contactDavid Deuchler,
CFAGilmartin Groupolink@gilmartinir.com
Media contactMichael B. GonzalesVP
Global MarketingMobile: +1 415 308
6467michael.gonzales@olink.com
Olink Holding AB (NASDAQ:OLK)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Olink Holding AB (NASDAQ:OLK)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025